Mahnaz Entezaralmahdi, MD
Pain Medicine · Rancho Cucamonga, CANPI 1881005445
Payments from drug & device makers
Across 89 payments — averaging $50.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Nevro Corp.$1K
- Stryker$723
- Abbott$662
- AbbVie$95
- Collegium Pharmaceutical, Inc.$93
- plus $155 from 5 others
Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$16
What the payments were for
- Travel & lodging$2,59158%
- Food & beverage$1,87542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 27 | $1,451 |
| Nevro Corp. | 10 | $1,288 |
| Stryker | 7 | $723 |
| Abbott | 26 | $662 |
| AbbVie | 6 | $95 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,466 in reported general payments places this provider in the 65th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 176 | $4,306 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $1,810 |
| Lidocaine | 17 | $1,169 |
| Gabapentin | 73 | $949 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $816 |
| Naloxone Hcl | 12 | $685 |
| Baclofen | 35 | $656 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $606 |
| Pregabalin | 22 | $462 |
| Diclofenac Sodium | 18 | $397 |
| Oxycodone Hcl | 26 | $385 |
| Tramadol Hcl | 42 | $271 |
| Tizanidine Hcl | 16 | $217 |
| Methocarbamol | 18 | $208 |
| Ibuprofen | 27 | $197 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Rancho Cucamonga
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
- Jacqueline WeisbeinNapa$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.